Trial Profile
Amlodipine/valsartan versus maximum-dose losartan in hypertensive patients also receiving hydrochlorothiazide
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 11 Jun 2011
Price :
$35
*
At a glance
- Drugs Amlodipine/valsartan (Primary) ; Hydrochlorothiazide; Losartan
- Indications Hypertension
- Focus Therapeutic Use
- Sponsors Novartis Pharmaceuticals Corporation
- 11 Jun 2011 New trial record
- 24 May 2011 Results presented at the 26th Annual Scientific Meeting of the American Society of Hypertension.